Anju Software Releases ta-Scan 360
Anju Software has released ta-Scan 360, a data platform integrating multiple sources for integrated views of clinical trials
Anju ta-Scan 360 offers the ability to incorporate multiple sources of data into a data lake without customers having to create complex data warehouses. The solution also allows for data export to customer-specific BI tools. The secured data can be analyzed and viewed using the new Anju Knowledge Graph.
For more information, click here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo
January 17th 2025Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a comparable safety and tolerability profile, further establishing its efficacy in obesity treatment.
